The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 17, 2022
Filed:
Jul. 16, 2018
Applicants:
Vib Vzw, Ghent, BE;
Katholieke Universiteit Leuven, K.u.leuven R&d, Leuven, BE;
Inventors:
Assignees:
VIB VZW, Ghent, BE;
Katholieke Univeriteit Leuven, K.U. Leuven R&D, Leuven, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 38/46 (2006.01); C12N 15/113 (2010.01); C12N 15/115 (2010.01); G01N 33/544 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 38/465 (2013.01); C12N 15/115 (2013.01); C12N 15/1138 (2013.01); G01N 33/544 (2013.01); C07K 2317/34 (2013.01); C07K 2317/76 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); G01N 2500/04 (2013.01);
Abstract
The invention relates to identification of synaptogyrin-3 as a target for treating or inhibiting progression of tauopathies or symptoms of tauopathies. In particular, synaptogyrin-3 inhibitors for use as a medicament in general, and for treating or inhibiting progression of tauopathies or symptoms of tauopathies are envisaged. The invention further relates to methods for identification of or for screening for inhibitors of synaptogyrin-3.